1-Ethyl-3-methyl-1H-pyrazole-5-carboxylic acid → 1-Ethyl-N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-3-methyl-1H-pyrazole-5-carboxamide
反応式
[CH2:1]([N:3]1[C:7]([C:8]([OH:10])=O)=[CH:6][C:5]([CH3:11])=[N:4]1)[CH3:2].F[P-](F)(F)(F)(F)F.CN(C(ON1C2=NC=CC=C2N=N1)=[N+](C)C)C.[NH:36]1[C:44]2[C:39](=[C:40]([C:45]3[CH:46]=[C:47]([NH2:54])[C:48]4[CH:49]=[N:50][NH:51][C:52]=4[CH:53]=3)[CH:41]=[CH:42][CH:43]=2)[CH:38]=[CH:37]1>CN(C=O)C.CCN(C(C)C)C(C)C>[CH2:1]([N:3]1[C:7]([C:8]([NH:54][C:47]2[CH:46]=[C:45]([C:40]3[CH:41]=[CH:42][CH:43]=[C:44]4[C:39]=3[CH:38]=[CH:37][NH:36]4)[CH:53]=[C:52]3[C:48]=2[CH:49]=[N:50][NH:51]3)=[O:10])=[CH:6][C:5]([CH3:11])=[N:4]1)[CH3:2]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
1-Ethyl-3-methyl-1H-pyrazole-5-carboxylic acid (67.8 mg) was treated with N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylidene]-N-methylmethanaminium hexafluorophosphate (168 mg) in DMF (750 μl) and DIPEA (150 μl). Reaction mixture was shaken for five min prior to treatment with 6-(1H-indol-4-yl)-1H-indazol-4-amine (50 mg) in DMF (350 μl). Reaction mixture was left to stand at 22° C. for 16 hrs. Solvent was removed in vacuo and the product re-dissolved in chloroform (0.3 ml) prior to application on to a preconditioned (methanol then chloroform) aminopropyl SPE cartridge (1 g). Product was eluted after 2 h with ethyl acetate:methanol (1:1, 3.2 ml), and concentrated under a stream of nitrogen using blow down apparatus. Purification by mass directed preparative HPLC (Method B) gave the title compound.
後処理
- customReaction mixture
- customReaction mixture
- waitwas left
- waitto stand at 22° C. for 16 hrs
- customSolvent was removed in vacuo
- dissolutionthe product re-dissolved in chloroform (0.3 ml)
- washProduct was eluted after 2 h with ethyl acetate:methanol (1:1, 3.2 ml)
- concentrationconcentrated under a stream of nitrogen using blow down apparatus
- customPurification by mass
出典と根拠
- ORDレコード
- ord-5aafeaabfc944540b2cc041bafca5b9a
- 出典データセット
- uspto-grants-2014_02
- 特許番号
- US08658635B2
反応ノート
読み込み中…